ArisGlobal Announces New Central Coding and Dictionary Management System
ArisGlobal, a provider of solutions to the life science industry, has announced the immediate availability of agEncoder 2.1, its comprehensive coding and dictionary management system.
The new release, certified by the Uppsala Monitoring Center to utilize the full features of WHO DRUG dictionary, offers new capabilities such as multi-lingual MedDRA support (including English, French, German, Italian, Japanese, Spanish, Portuguese, Czech, Hungarian and Dutch). agEncoder also extends support of standardized MedDRA Queries (SMQs) and Custom MedDRA Queries (CMQs) including improved search capabilities and full impact analysis of new MedDRA versions.
Integrated with ArisGlobal’s pharmacovigilance and safety system (ARISg) and the company’s electronic data capture technology (agCapture), agEncoder offers comprehensive dictionary management and centralized coding with integrated workflow to ensure accurate and consistent coding of clinical terms. Further functionality enhancements include improved search capability of the WHO-DD browser (e.g. search for active ingredients, search for preferred terms, generic terms, drug synonyms and umbrella search) and the use of eSignature.
Commented Mathias Poensgen, product manager. “agEncoder 2.1 serves the coding needs of both pharmacovigilance and clinical teams to improve the quality as well as the efficiency of their coding process.”
agEncoder 2.1 will be available to customers as a licensed, on-premise solution or as a hosted solution via agOnDemand™, ArisGlobal's comprehensive Software-as-a-Service (SaaS) delivery platform.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
